Dr. Alexander Spira Discusses Advances In Non-Small Cell Lung Cancer

Dr. Alexander Spira Discusses Advances in Non-Small Cell Lung Cancer (NSCLC)

J&J Innovative Medicine

First line treatment options for activating EGFR non-small cell lung Cancer | Dr. Alexander Spira

OncBrothers: Practice-Changing Cancer Discussions

New Standard of care Treatment for EGFR Exon 20 Non-small cell Lung Cancer | Dr. Alexander Spira

OncBrothers: Practice-Changing Cancer Discussions

ASCO 2020: Latest developments in EGFR-mutated non-small cell lung cancer

Advances in Non-Small Cell Lung Cancer Testing

Patient Empowerment Network

Alexander Spira, MD, PhD, FACP, on managing lung cancer patients in a community setting

Alex Spira, MD, PhD, FACP, discusses the mechanism of action of amivantamab (JNJ-6372)

Alexander Spira, MD, PhD, FACP, on the recent approval of atezolizumab in SCLC

ASCO 2022: Dr. Alexander I. Spira on KRYSTAL-1 for Patients with Advanced/Metastatic NSCLC

Introduction: Advances and Issues in Non-Small Cell Lung Cancer

Alex Spira, MD, PhD, FACP, offers thoughts on the four-year follow-up to the Phase III PACIFIC trial

State-of-the-Art in Combination Immuno/Radiotherapy for Non-Small Cell Lung Cancer

Advances in metastatic non small cell lung cancer

Alex Spira, MD, PhD, FACP, shares thoughts on the Phase I CHRYSALIS study presented at ESMO 2020

Physician Spotlight: Alex Spira, M.D., PhD, F.A.C.P., Medical Oncologist

Virginia Cancer Specialists

Dr. Spira on the POPLAR Study for NSCLC

Dr Alex Spira speaks about the latest anti PDL1 study

Patient Empowerment Network

Immunotherapy induces 'striking' responses in non-small cell lung cancer

MDedge: news and insights for busy physicians

Immunotherapy for Previously Treated Advanced Non-Small Cell Lung Cancer

GRACE - Global Resource for Advancing Cancer Education

Drs. Leighl, Sabari, & Spira discuss #NSCLC at #TTLC23 - https://bit.ly/3jUyvuN

PeerView Oncology